pubmed-article:16014030 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C0067033 | lld:lifeskim |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C0010834 | lld:lifeskim |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
pubmed-article:16014030 | lifeskim:mentions | umls-concept:C1145667 | lld:lifeskim |
pubmed-article:16014030 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16014030 | pubmed:dateCreated | 2005-7-14 | lld:pubmed |
pubmed-article:16014030 | pubmed:abstractText | Recently, the in vivo pathogenic role of anti-neutrophil cytoplasm autoantibodies (ANCA) in ANCA-associated vasculitis has been challenged by Abdel-Salam et al. In their report, they observed that ANCA directed against proteinase 3 (PR3) cannot bind to their target autoantigen PR3 on circulating neutrophils (PMN). Here we present evidence that human PR3-ANCA do specifically bind to PMN that express PR3 on their membrane. | lld:pubmed |
pubmed-article:16014030 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:language | eng | lld:pubmed |
pubmed-article:16014030 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16014030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16014030 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16014030 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16014030 | pubmed:issn | 0085-2538 | lld:pubmed |
pubmed-article:16014030 | pubmed:author | pubmed-author:KallenbergCee... | lld:pubmed |
pubmed-article:16014030 | pubmed:author | pubmed-author:LimburgPieter... | lld:pubmed |
pubmed-article:16014030 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:16014030 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:16014030 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16014030 | pubmed:volume | 68 | lld:pubmed |
pubmed-article:16014030 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16014030 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16014030 | pubmed:pagination | 537-41 | lld:pubmed |
pubmed-article:16014030 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:meshHeading | pubmed-meshheading:16014030... | lld:pubmed |
pubmed-article:16014030 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16014030 | pubmed:articleTitle | Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. | lld:pubmed |
pubmed-article:16014030 | pubmed:affiliation | Department of Rheumatology and Clinical Immunology, Groningen University Medical Centre, Groningen, The Netherlands. | lld:pubmed |
pubmed-article:16014030 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16014030 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16014030 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16014030 | lld:pubmed |